SPECT imaging evaluation of 111indium-chelated cetuximab for diagnosing EGFR-positive tumor in an HCT-15-induced colorectal xenograft
Conclusion We suggested that the 111In-cetuximab was potential for early diagnosis and prognostic monitor of EGFR-positive CRC in further clinical practice.
Source: Journal of the Chinese Medical Association - Category: General Medicine Source Type: research
More News: Acetic Acid | Cancer | Cancer & Oncology | Chia | China Health | Colorectal Cancer | Erbitux | General Medicine | Nutrition | SPECT | Study